RoboDesign's CrystalMation Technology to Be Installed at Novartis Institutes for BioMedical Research in Basel, Switzerland
Advertisement
Carlsbad, California. RoboDesign International, Inc., announced that the Novartis Institutes for BioMedical Research (NIBR) in Basel, Switzerland (Novartis AG), has selected CrystalMation(TM) as a platform for its protein crystal imaging and analysis. CrystalMation, a fully modular and automated protein crystallization system, includes equipment for liquid handling, low volume dispense, imaging, storage and analysis.
NIBR will be integrating RoboDesign's Minstrel III(TM) and RoboIncubator(TM) combinations, the core of the CrystalMation technology, at their Basel site beginning in June 2004. The Minstrel III, an ultra-high resolution imaging system, can quickly and consistently image hanging, sitting, or microbatch drops in any plate type. As with all of the CrystalMation components, the Minstrel III was designed to be expandable and modular, and can be expanded with a wide array of software tools and multiple RoboIncubators, a temperature controlled plate storage and retrieval system.
Robert L. Corey, president and CEO of RoboDesign stated, "NIBR needs a protein crystal imaging and analysis system that could meet their demanding requirements for performance and reliability. As with our continuing relationships with many of the world's leading pharmaceutical, biotech, and research organisations, NIBR's decision to implement our technology further validates CrystalMation as a leading protein crystallization platform. We are pleased and excited to be working with the research division of Novartis, a world leader in helping to improve patients lives and look forward to a long and successful relationship."
Other news from the department business & finance
These products might interest you
Most read news
More news from our other portals
Last viewed contents
Antihypertensive drugs may protect against Alzheimer's disease - Drugs may promote memory function and reduce cognitive deterioration without influencing blood pressure
SEQUENOM and National Institutes of Health Expand Relationship for Gene Expression - Agreement Builds on Success of Previous SNP Genotyping Research
Muscle-Targeted Gene Therapy Reverses Rare Muscular Dystrophy in Mice
Study finds 'mad cow disease' in cattle can spread widely in ANS before detectable in CNS
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer - Using UV light, radiolabelled antibodies can be produced in just 15 minutes
Bioactive natural compounds for the fight against cancer - New synthesis route manages without toxic and expensive oxidizing agent and at the same time proves to be much more efficient
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant - Thymoglobulin Fill/Finishing to Begin Immediately
A fruit a day may keep Alzheimer's at bay, suggests new Cornell study
Ear wax as a possible screening medium for Parkinson’s disease
BASF invests in biotechnology start-up Bota Bio - Bota Bio’s next-generation industrial biology platform is a combination of computation and cutting-edge biotechnology
